Co-Authors
This is a "connection" page, showing publications co-authored by Amber Jarnecke and Delisa Brown.
Connection Strength
0.680
-
Examining the role of social support in treatment for co-occurring substance use disorder and posttraumatic stress disorder. Addict Behav Rep. 2022 Jun; 15:100427.
Score: 0.217
-
Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment. J Ethn Subst Abuse. 2022 Jul-Sep; 21(3):1141-1164.
Score: 0.196
-
COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans. Contemp Clin Trials. 2023 03; 126:107084.
Score: 0.057
-
Technology-enhanced in vivo exposures in Prolonged Exposure for PTSD: A pilot randomized controlled trial. J Psychiatr Res. 2022 Nov 01; 156:467-475.
Score: 0.056
-
Enhancing Prolonged Exposure therapy for PTSD using physiological biomarker-driven technology. Contemp Clin Trials Commun. 2022 Aug; 28:100940.
Score: 0.055
-
Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder. Drug Alcohol Depend. 2021 08 01; 225:108755.
Score: 0.051
-
N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
Score: 0.047